SCHEMBL16882157

SCHEMBL16882157

NC[C@H]1O[C@@H](OC2[C@H](O[C@H]3OC(CO)[C@@H](O)C(O)C3N)C(N)C[C@@H](N)[C@H]2O)[C@@H](O)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 1.00
TSHR P16473 2/20 0.91
HSD17B10 Q99714 1/20 0.91
LRAT O95237 2/20 0.88
MEN1 O00255 2/20 0.88
TRPV1 Q8NER1 1/20 0.88
BLM P54132 1/20 0.81
RECQL P46063 1/20 0.81
TDP1 Q9NUW8 1/20 0.81
KDM4E B2RXH2 1/20 0.78
ALOX15 P16050 1/20 0.78
GJA1 P17302 1/20 0.72
GJB2 P29033 1/20 0.72
CYP2C9 P11712 1/20 0.72
KMT2A Q03164 1/20 0.72
ALDH1A1 P00352 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribostamycin SCHEMBL48820 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
Ribostamycin SCHEMBL13599669 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
Ribostamycin SCHEMBL19944115 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
Ribostamycin SCHEMBL13605470 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
Ribostamycin SCHEMBL15432715 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
SCHEMBL19619289 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
SCHEMBL19619262 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
SCHEMBL17321247 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
Ribostamycin SCHEMBL20530016 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1
Ribostamycin SCHEMBL48819 1.00 LMNA (1.00) LMNATSHRHSD17B10LRATMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073958-B2 Aminoglycosides and uses thereof in the treatment of genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2015-07-07 US disclosed